Company Filing History:
2 out of 3 
1 out of 156 
1 out of 5,307 
Years Active: 2002-2016
Title: The Innovative Contributions of Inventor Peter Nelson
Introduction
Peter Nelson, an accomplished inventor based in Munich, Germany, has made significant strides in the field of biotechnology. With a total of five patents to his name, his work primarily focuses on the treatment of tumors and cancer through innovative methodologies involving genetically modified cells.
Latest Patents
Among his latest patents, one noteworthy invention is a genetically modified mesenchymal stem cell that expresses an exogenous cytotoxic protein. This pioneering concept provides a method for treating subjects afflicted with tumors, utilizing the unique characteristic of these modified stem cells to selectively express cytotoxic proteins near tumor stromal tissue. Another of his significant inventions includes the use of tissue inhibitors of metalloproteinases (TIMP) linked to glycosylphosphatidylinositol (GPI) anchors for treating cancer and skin lesions. This approach involves creating fusion constructs that enable TIMP proteins to integrate into tumor cell membranes, thus making them sensitive to apoptosis and enhancing wound healing applications.
Career Highlights
Throughout his career, Peter Nelson has been associated with Apceth GmbH & Co. KG, where his innovations have been recognized for their potential impact on cancer treatment and regenerative medicine. His expertise in genetic modification techniques has placed him at the forefront of advancements in these critical health domains.
Collaborations
In his journey, he has collaborated with notable colleagues including Ralf Huss and Matthias C. Raggi. Together, they have worked on various projects aimed at enhancing therapeutic options for patients suffering from challenging ailments, particularly in oncology.
Conclusion
Peter Nelson's contributions to the field of biotechnology and his innovative patents highlight the importance of interdisciplinary collaboration and novel approaches to tackling serious health issues like cancer. His work not only advances scientific understanding but also holds the promise of improved treatment methodologies for patients in need.